classify medetomidine as a Schedule III controlled substance and establish permissible uses.

Plain English Breakdown

Using official source text because the generated explanation was unavailable or could not be confirmed against the official bill text.

classify medetomidine as a Schedule III controlled substance and establish permissible uses.

classify medetomidine as a Schedule III controlled substance and establish permissible uses.

What This Bill Does

• classify medetomidine as a Schedule III controlled substance and establish permissible uses.
• Official keyword topics: Controlled Substances Public Health and Safety Official sponsor note: Representatives <a rel="noopener" href="https://sdlegislature.gov/Legislators/Profile/4752/Detail">Garcia</a> (prime), <a rel="noopener" href="https://sdlegislature.gov/Legislators/Profile/4731/Detail">Andera</a>, <a rel="noopener" href="https://sdlegislature.gov/Legislators/Profile/4766/Detail">Hunt</a>, <a rel="noopener" href="https://sdlegislature.gov/Legislators/Profile/4767/Detail">Ismay</a>, <a rel="noopener" href="https://sdlegislature.gov/Legislators/Profile/4770/Detail">Jensen (Phil)</a>, <a rel="noopener" href="https://sdlegislature.gov/Legislators/Profile/4771/Detail">Jordan</a>, <a rel="noopener" href="https://sdlegislature.gov/Legislators/Profile/4796/Detail">Novstrup</a>, <a rel="noopener" href="https://sdlegislature.gov/Legislators/Profile/4811/Detail">Rice</a>, and <a rel="noopener" href="https://sdlegislature.gov/Legislators/Profile/4816/Detail">Schaefbauer</a> and Senator <a rel="noopener" href="https://sdlegislature.gov/Legislators/Profile/4756/Detail">Grove</a> (prime)

Limits and Unknowns

• This entry is temporarily using official source text because the generated explanation could not be confirmed against the official bill text during the last sync.

Official Summary Text

classify medetomidine as a Schedule III controlled substance and establish permissible uses.
Official keyword topics:
Controlled Substances
Public Health and Safety
Official sponsor note: Representatives <a rel="noopener" href="https://sdlegislature.gov/Legislators/Profile/4752/Detail">Garcia</a> (prime), <a rel="noopener" href="https://sdlegislature.gov/Legislators/Profile/4731/Detail">Andera</a>, <a rel="noopener" href="https://sdlegislature.gov/Legislators/Profile/4766/Detail">Hunt</a>, <a rel="noopener" href="https://sdlegislature.gov/Legislators/Profile/4767/Detail">Ismay</a>, <a rel="noopener" href="https://sdlegislature.gov/Legislators/Profile/4770/Detail">Jensen (Phil)</a>, <a rel="noopener" href="https://sdlegislature.gov/Legislators/Profile/4771/Detail">Jordan</a>, <a rel="noopener" href="https://sdlegislature.gov/Legislators/Profile/4796/Detail">Novstrup</a>, <a rel="noopener" href="https://sdlegislature.gov/Legislators/Profile/4811/Detail">Rice</a>, and <a rel="noopener" href="https://sdlegislature.gov/Legislators/Profile/4816/Detail">Schaefbauer</a> and Senator <a rel="noopener" href="https://sdlegislature.gov/Legislators/Profile/4756/Detail">Grove</a> (prime)

Current Bill Text

26.708.10 101st Legislative Session 1169

2026 South Dakota Legislature
House Bill 1169
ENROLLED

AN ACT

ENTITLED An Act to classify medetomidine as a Schedule III controlled substance
and establish permissible uses.
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF SOUTH DAKOTA:
Section 1. That a NEW SECTION be added to chapter 34-20B:
Any material, compound, mixture, or preparation that contains medetomidine is a
Schedule III controlled drug or substance, except in the following cases:
(1) Dispensing, prescribing, or administering, to an animal, a drug that contains
medetomidine and has been approved by the United States secretary of health and
human services under 21 U.S.C. § 360b (January 1, 2026);
(2) Dispensing, prescribing, or administering medetomidine to an animal, as
permissible under 21 U.S.C. § 360b(a)(4) (January 1, 2026);
(3) Manufacturing, distributing, or using medetomidine as an active pharmaceutical
ingredient for manufacturing an animal drug:
(a) Approved under 21 U.S.C. § 360b (January 1, 2026); or
(b) Issued an investigational use exemption under 21 U.S.C. § 360b(j)
(January 1, 2026);
(4) Manufacturing, distributing, or using a medetomidine bulk chemical for
pharmaceutical compounding by a licensed pharmacist or veterinarian; or
(5) Any other use approved or permissible under 21 U.S.C. §§ 301 to 399i, inclusive
(January 1, 2026).
26.708.10 2 1169
HB1169 ENROLLED
An Act to classify medetomidine as a Schedule III controlled substance and establish
permissible uses.

I certify that the attached Act originated in
the:

House as Bill No. 1169

Chief Clerk of the House

Speaker of the House

Attest:

Chief Clerk of the House

President of the Senate

Attest:

Secretary of the Senate

House Bill No. 1169
File No. ____
Chapter No. ______

Received at this Executive Office
this _____ day of _____________,

2026 at ____________M.

By
for the Governor

The attached Act is hereby
approved this ________ day of
______________, A.D., 2026

Governor

STATE OF SOUTH DAKOTA,
ss.
Office of the Secretary of State

Filed ____________, 2026
at _________ o'clock __M.

Secretary of State

By
Asst. Secretary of State